Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Merve Bıyıklı Alemdar
Institution:
Adnan Menderes University
Observed institution:
Adnan Menderes University
ORCID:
0000-0001-6833-8217
Observed ORCID:
0000-0001-6833-8217
OpenAlex ID:
A5113331416
Investigation of Possible Positive Effects of Arbutin Application in Experimental Colitis Model
2024
·
Merve Bıyıklı Alemdar
, Ferhat Şirinyıldız
, et al.
·
The Turkish Journal of Gastroenterology
·
5
PDF
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
2026
·
Salih Tunbekici
, Hamit Bal
, et al.
·
Clinical & Translational Oncology
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study
2025
·
Alper Türkel
, İlknur Deliktaş Onur
, et al.
·
Clinical Breast Cancer
Diagnostic Value of Circulating miRNA-16-5p and miRNA-221-3p in Thyroid Cancer
2025
·
Esin Oktay
, Merve Bıyıklı Alemdar
, et al.
·
Meandros Medical And Dental Journal
PDF
Factors Affecting Arterial Stiffness Level in Cancer Patients Receiving Immunotherapy
2025
·
Esra Güner
, Merve Bıyıklı Alemdar
, et al.
·
Meandros Medical And Dental Journal
CEA and CA 19-9 combined tumor marker index as a prognostic tool for metastatic pancreatic cancer: is two better than one?
2025
·
Bilgin Demir
, Merve Bıyıklı Alemdar
, et al.
·
American Journal of Cancer Research
PDF
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type
